A simultaneous pancreas-kidney transplantation for type 1 diabetes mellitus after a long-term of receiving hemodialysis renal replacement therapy. Clinical сase

At the present time, a simultaneous pancreas-kidney transplantation (SPKT) is an effective method of treatment for patients on renal replacement therapy by hemodialysis program in the outcome of the terminal stage of diabetic nephropathy. This method of treatment solves several problems: it reduces the severity of intoxication syndrome, contributes to the achievement of euglycemia in most cases, which certainly allows to slow the progression of micro- and macrovascular complications of diabetes. Despite of positive effect of euglycaemia and kidney function normalization, the accumulated metabolic memory legacy of long-term uncompensated diabetes mellitus is realized, which makes a posttransplantational rehabilitation of patients difficult. A duration of hemodialysis therapy is known as a cardiovascular events risk factor, which affects the surgery result and favorable posttransplant period. More often after successful SPKT microvascular diabetic complications are stabilized, but macrovascular diabetic complications, diabetic neuroosteoarthropathy and mineral and bone disease are progressed. That’s why is necessary to perform regular examination after SPKT by a team of specialists, including nephrologist, endocrinologist, cardiologist, ophthalmologist with correction of ongoing therapy. Therefore both the preparation of  the patient for transplantation with the earliest possible placement on the waiting list and the post-transplant rehabilitation afterwards are extremely important.

1. Hau H-M, Jahn N, Rademacher S, et al. The Value of Graft Implantation Sequence in Simultaneous Pancreas-Kidney Transplantation on the Outcome and Graft Survival. J Clin Med. 2021;10(8):1632. doi: https://doi.org/10.3390/jcm10081632

2. van Dellen D, Worthington J, Mitu-Pretorian OM, et al. Mortality in diabetes: pancreas transplantation is associated with significant survival benefit. Nephrol Dial Transplant. 2013;28(5):1315-1322. doi: https://doi.org/10.1093/ndt/gfs613

3. Glazunova AM, Kvaratschelia MV, Shamkhalova MSh, Shestakova MV. Simultaneous pancreas-kidney transplantation: Pro et Contra. 2011;14(4):32-37. (In Russ). doi: https://doi.org/10.14341/2072-0351-5814

4. Gruessner RW, Gruessner AC. The current state of pancreas transplantation. Nat Rev Endocrinol. 2013;9(9):555-562. doi: https://doi.org/10.1038/nrendo.2013.138

5. Poggio ED, Augustine JJ, Arrigain S, et al. Long-term kidney transplant graft survival. Making progress when most needed. Am J Transplant. 2021;21(8):2824-2832. doi: https://doi.org/10.1111/ajt.16463

6. Grochowiecki T, Gałązka Z, Madej K, et al. Surgical complications related to transplanted pancreas after simultaneous pancreas and kidney transplantation. Transplant Proc. 2014;46(8):2818-2821. doi: https://doi.org/10.1016/j.transproceed.2014.08.012.

7. Sansalone CV, Maione G, Aseni P, et al. Surgical complications are the main cause of pancreatic allograft loss in pancreas-kidney transplant recipients. Transplant Proc. 2005;37(6):2651-2653. doi: https://doi.org/10.1016/j.transproceed.2005.06.103

8. Michalak G, Kwiatkowski A, Czerwinski J, et al. Surgical complications of simultaneous pancreas-kidney transplantation: a 16-year-experience at one center. Transplant Proc. 2005;37(8):3555-3557. doi: https://doi.org/10.1016/j.transproceed.2005.09.077

9. Grochowiecki T, Gałązka Z, Madej K, et al. Early complications related to the transplanted kidney after simultaneous pancreas and kidney transplantation. Transplant Proc. 2014;46(8):2815-2817. doi: https://doi.org/10.1016/j.transproceed.2014.08.011

10. Morath C, Zeier M, Döhler B, et al. Transplantation of the type 1 diabetic patient: the long-term benefit of a functioning pancreas allograft. Clin J Am Soc Nephrol. 2010;5(3):549-552. doi: https://doi.org/10.2215/CJN.03720609

11. Esmeijer K, Hoogeveen EK, Van Den Boog PJM, et al. Superior long-term survival for simultaneous pancreas-kidney transplantation as renal replacement therapy: 30-year follow-up of a nationwide cohort. Diabetes Care. 2020;43(2):321-328. doi: https://doi.org/10.2337/DC19-1580/-/DC1

12. Dong Y, Zhou J, Li Z, et al. Influence of dialysis duration on outcomes of simultaneous pancreas-kidney transplant. Clin Transplant. 2021;35(4). doi: https://doi.org/10.1111/CTR.14238

13. Browne S, Gill J, Dong J, et al. The impact of pancreas transplantation on kidney allograft survival. Am J Transplant. 2011;11(9):1951-1958. doi: https://doi.org/10.1111/J.1600-6143.2011.03627.X

14. Mauer M, Fioretto P. Pancreas transplantation and reversal of diabetic nephropathy lesions. Med Clin North Am. 2013;97(1):109-114. doi: https://doi.org/10.1016/J.MCNA.2012.10.009

15. Boggi U, Rosati CM, Marchetti P. Follow-up of secondary diabetic complications after pancreas transplantation. Curr Opin Organ Transplant. 2013;18(1):102-110. doi: https://doi.org/10.1097/MOT.0b013e32835c28c5

16. Fioretto P, Steffes MW, Sutherland DE, et al. Reversal of lesions of diabetic nephropathy after pancreas transplantation. N Engl J Med. 1998;339(2):69-75. doi: https://doi.org/10.1056/NEJM199807093390202

17. Lindahl JP, Jenssen T, Hartmann A. Long-term outcomes after organ transplantation in diabetic end-stage renal disease. Diabetes Res Clin Pract. 2014;105(1):14-21. doi: https://doi.org/10.1016/J.DIABRES.2014.03.004

18. Donegan D, Hickey DP, Smith D. Hypoglycemia after simultaneous pancreas-kidney transplant: fact or factitious? Pancreas. 2012;41(6):974-976. doi: https://doi.org/10.1097/MPA.0B013E31823FB6FF

19. Battezzati A, Bonfatti D, Benedini S, et al. Spontaneous hypoglycaemia after pancreas transplantation in Type 1 diabetes mellitus. Diabet Med. 1998;15(12):991-996. doi: https://doi.org/10.1002/(SICI)1096-9136(1998120)15:12<991::AID-DIA717>3.0.CO;2-Q

20. Esmatjes E, Flores L, Vidal M, et al. Hypoglycaemia after pancreas transplantation: usefulness of a continuous glucose monitoring system. Clin Transplant. 2003;17(6):534-538. doi: https://doi.org/10.1046/J.1399-0012.2003.00101

21. Vangala C, Pan J, Cotton RT, Ramanathan V. Mineral and Bone Disorders After Kidney Transplantation. Front Med (Lausanne). 2018;5:211. doi: https://doi.org/10.3389/fmed.2018.00211

22. ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J. 2011;32:1769–818.

23. Kidney Disease: Improving Global Outcomes (KDIGO) Lipid Work Group. KDIGO Clinical Practice Guideline for Lipid Management in Chronic Kidney Disease. Kidney Int. (Suppl.) 2013;3:259-305.